Epizyme Gets $90 Million in Epigenetics Partnership With Celgene Corporation

Epizyme and Celgene International Srl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today announced the formation of a strategic partnership to discover, develop and commercialize personalized t…
Read the full story: BioSpace.com Featured News